AB
TBPH icon

Amalgamated Bank’s Theravance Biopharma TBPH Stock Holding History

Amalgamated Bank’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,190
Closed -$22K – 2690
2025
Q4 		$22K Sell
1,190
-62
-5% -$1.03K ﹤0.01% 2075
2025
Q3 		$18K Hold
1,252
– – ﹤0.01% 2179
2025
Q2 		$14K Hold
1,252
– – ﹤0.01% 2287
2025
Q1 		$11K Hold
1,252
– – ﹤0.01% 2344
2024
Q4 		$12K Sell
1,252
-473
-27% -$4.3K ﹤0.01% 2365
2024
Q3 		$14K Hold
1,725
– – ﹤0.01% 2300
2024
Q2 		$15K Hold
1,725
– – ﹤0.01% 2251
2024
Q1 		$15K Sell
1,725
-3,832
-69% -$35.5K ﹤0.01% 2272
2023
Q4 		$62K Sell
5,557
-671
-11% -$6.75K ﹤0.01% 2152
2023
Q3 		$54K Hold
6,228
– – ﹤0.01% 2225
2023
Q2 		$64K Sell
6,228
-2,611
-30% -$28.8K ﹤0.01% 2223
2023
Q1 		$96K Sell
8,839
-1,285
-13% -$13.6K ﹤0.01% 2072
2022
Q4 		$114K Hold
10,124
– – ﹤0.01% 2089
2022
Q3 		$103K Buy
10,124
+146
+1% +$1.37K ﹤0.01% 2134
2022
Q2 		$90K Buy
9,978
+422
+4% +$3.89K ﹤0.01% 2210
2022
Q1 		$91K Sell
9,556
-769
-7% -$7.54K ﹤0.01% 2231
2021
Q4 		$114K Sell
10,325
-234
-2% -$2.04K ﹤0.01% 2050
2021
Q3 		$78K Buy
+10,559
New +$118K ﹤0.01% 2104
2020
Q1 		– Sell
-8,024
Closed -$208K – 1770
2019
Q4 		$208K Buy
+8,024
New +$156K ﹤0.01% 1619
2017
Q3 		– Sell
-5,360
Closed -$214K – 1603
2017
Q2 		$214K Buy
+5,360
New +$206K 0.01% 1392

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Bank's TBPH Position: Q1 2026 in Review

Amalgamated Bank sold out of Theravance Biopharma (TBPH) in Q1 2026, closing a stake of 1,190 shares — an estimated $22K sold.

Amalgamated Bank first reported a position in TBPH in Q2 2017 and held it in 20 quarters. The position peaked at $214K in Q2 2017. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Amalgamated Bank reported no remaining Theravance Biopharma position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,190 Theravance Biopharma shares in Q1 2026, an estimated $22K.
  • Amalgamated Bank first reported a position in Theravance Biopharma in Q2 2017 and held it in 20 quarters.
  • Amalgamated Bank's Theravance Biopharma position peaked at $214K in Q2 2017.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.